scholarly article | Q13442814 |
P50 | author | Charlie Tomson | Q51105169 |
Matthew C Pickering | Q55692581 | ||
P2093 | author name string | H Terence Cook | |
Talat H Malik | |||
Nicholas Medjeral-Thomas | |||
Mitali P Patel | |||
Tibor Toth | |||
P2860 | cites work | Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis | Q24615589 |
Dimerization of complement factor H-related proteins modulates complement activation in vivo | Q27676814 | ||
Factor H family proteins: on complement, microbes and human diseases | Q33345389 | ||
Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. | Q33378236 | ||
Location and structure of the human FHR-5 gene | Q34131162 | ||
Genome-wide association study identifies susceptibility loci for IgA nephropathy | Q34170453 | ||
Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees | Q35030648 | ||
A hybrid CFHR3-1 gene causes familial C3 glomerulopathy. | Q36050943 | ||
C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation | Q36891110 | ||
Recent insights into C3 glomerulopathy | Q38088187 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 933-937 | |
P577 | publication date | 2013-09-25 | |
P1433 | published in | Kidney International | Q6404823 |
P1476 | title | A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry | |
P478 | volume | 85 |
Q37682273 | American Society of Nephrology clinical pathological conference |
Q51730313 | An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy. |
Q39207807 | C3 glomerulopathy |
Q52339140 | C3 glomerulopathy in cystic fibrosis: a case report. |
Q37348685 | C3 glomerulopathy: consensus report |
Q40136434 | Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy |
Q34455125 | Defining the complement biomarker profile of C3 glomerulopathy |
Q37017177 | Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury. |
Q47111288 | Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma |
Q38275117 | Histopathology of MPGN and C3 glomerulopathies |
Q38549182 | Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach. |
Q64039347 | Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations |
Q92030175 | Novel CFHR2-CFHR1 Hybrid in C3 Glomerulopathy Identified by Genomic Structural Variation Analysis |
Q35567846 | Pathogenesis of glomerular haematuria. |
Q55385450 | Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin-Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H-Related Protein-5 (FHR5) Deposition. |
Q26741542 | Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN |
Q58803464 | Reference Intervals of Factor H and Factor H-Related Proteins in Healthy Children |
Q64044064 | Self-Damage Caused by Dysregulation of the Complement Alternative Pathway: Relevance of the Factor H Protein Family |
Q37032691 | The Genetics of Ultra-Rare Renal Disease |
Q38991052 | The complement factor H-related proteins |
Q40744602 | Update on C3 glomerulopathy. |
Search more.